Uruguay-based medical cannabis operator NetCann announced Wednesday a new partnership with Megalabs, one of Latin America’s leading pharmaceutical companies.

Under the agreement, Megalabs will have rights to distribute NetCann’s branded pharmaceutical products across 27 countries in Latin America.

“As a leading global pharmaceutical laboratory, the partnership between Megalabs and NetCann is a major milestone for the rapidly growing cannabis industry in Latin America. This partnership will ensure that NetCann has the capability to reach both international and Latin American markets and, as a leading GMP certified producer in the region, NetCann will continue to execute on our strategic growth plan to expand our production, reach, and patient access to the highest quality cannabis,” Gabriel Rodriguez, founder of NetCann, told Benzinga.

NetCann produces cannabis in Uruguay under the rigorous agricultural and pharmaceutical standards.

Also based in Uruguay, Megalabs boasts 17 pharmaceutical plants and 6 R&D centers in Latin America.

Encuentra nuestro contenido sobre cannabis y otros teams en Español en El Planteo:

• La Biblia de los Restaurantes: Dónde Comer en Montevideo, Uruguay

• The La Planta: Cumbia Cannábica a la Conquista del Mundo Entero

• Willie Nelson Es el Héroe que la Industria del Cannabis Necesita

See more from Benzinga

• Click here for options trades from Benzinga

• New Cannabis Products: 3 Weed-Themed Options For Pride Month

• Holistic Industries Opened Its Michigan Cannabis Headquarters And We Were There

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.